Preventive Care Services

Preventive Services Covered Under the Affordable Care Act and Nevada Revised Statutes

If you have a new health insurance plan or insurance policy beginning on or after September 23, 2010, the following preventive services must be covered without your having to pay a copayment or co-insurance or meet your deductible. This applies only when these services are delivered by a network provider.

• Covered Preventive Services for Adults and Families
• Covered Preventive Services for Women, Including Pregnant Women  
• Covered Vaccine Services for Infants, Children, Teens and Adults
• Nevada AB249 and SB233 mandates effective January 1, 2018

Nevada Wellness - Get Out! Get Healthy!

Along with preventive testing and services we cannot overestimate the powerful impact on health by a personal focus on your own wellness.  Nevada now offers an encompassing site to get involved with the growing trend toward personal wellness.  The below link will open up opportunities to exciting and rewarding individual and group experiences.

Nevada Wellness - Get Out! Get Healthy!

In addition to the required federal services, Nevada’s 79^thSession has further stipulated the below health mandates in Assembly Bill 249 and Senate Bill 233. These became effective on January 1, 2018 and apply to all Nevada Health Benefit Plans:

The following 18 methods of contraception must be covered as dispensed pursuant to Section 1 below: 

 (a) Voluntary sterilization for women;  
 (b) Surgical sterilization implants for women; 
 (c) Implantable rods; 
 (d) Copper-based intrauterine devices; 
 (e) Progesterone-based intrauterine devices; 
 (f) Injections; 
 (g) Combined estrogen- and progestin-based drugs; 
 (h) Progestin-based drugs; 
 (i) Extended- or continuous-regimen drugs; 
 (j) Estrogen- and progestin-based patches; 
 (k) Vaginal contraceptive rings; 
 (l) Diaphragms with spermicide; 
 (m) Sponges with spermicide; 
 (n) Cervical caps with spermicide; 
 (o) Female condoms; 
 (p) Spermicide;  
 (q) Combined estrogen- and progestin-based drugs for emergency contraception or progestin-based drugs for emergency contraception; and 
 (r) Ulipristal acetate for emergency contraception. 
 Coverage for contraception must include: 
 (a) Insertion of a device for contraception or removal of such a device if the device was inserted while the insured was covered by the same health care plan; 
 (b) Education and counseling relating to the initiation of the use of contraception and any necessary follow-up after initiating such use; 
 (c) Management of side effects relating to contraception; and 
 (d) Voluntary sterilization for women. 

 Section 1. Pursuant to a valid prescription or order for a drug to be used for contraception or its therapeutic equivalent which has been approved by the Food and Drug Administration: 

 (a) The first time dispensing the drug or therapeutic equivalent to the patient, up to a 3-month supply of the drug or therapeutic equivalent. 
 (b) The second time dispensing the drug or therapeutic equivalent to the patient, up to a 9-month supply of the drug or therapeutic equivalent, or any amount which covers the remainder of the plan year if the patient is covered by a health care plan, whichever is less. 
 (c) For a refill in a plan year following the initial dispensing of a drug or therapeutic equivalent, up to a 12-month supply of the drug or therapeutic equivalent or any amount which covers the remainder of the plan year if the patient is covered by a health care plan, whichever is less. 

 Coverage must be provided for the following:   

 (a) Counseling, support and supplies for breastfeeding, including breastfeeding equipment, counseling and education during the antenatal, perinatal and postpartum period for not more than 1 year;  
 (b) Screening and counseling for interpersonal and domestic violence for women at least annually with initial intervention services consisting of education, strategies to reduce harm, supportive services or a referral for any other appropriate services; 
 (c) Behavioral counseling concerning sexually transmitted diseases from a provider of health care for sexually active women who are at increased risk for such diseases; 
 (d) Hormone replacement therapy;  
 (e) Such prenatal screenings and tests as recommended by the American College of Obstetricians and Gynecologists or its successor organization; 
 (f) Screening for blood pressure abnormalities and diabetes, including gestational diabetes, after at least 24 weeks of gestation or as ordered by a provider of health care; (g) Screening for cervical cancer at such intervals as are recommended by the American College of Obstetricians and Gynecologists or its successor organization; 
 (h) Screening for depression; 
 (i) Screening and counseling for the human immunodeficiency virus consisting of a risk assessment, annual education relating to prevention and at least one screening for the 
 virus during the lifetime of the insured or as ordered by a provider of health care; 
 (j) Smoking cessation programs for an insured who is 18 years of age or older consisting of not more than two cessation attempts per year and four counseling sessions per year; (k) All vaccinations recommended by the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention of the United States Department of Health and Human Services or its successor organization; 
 (l) Such well-woman preventative visits as recommended by the Health Resources and Services Administration, which must include at least one such visit per year beginning at 14 years of age; 
 (j) Benefits payable for expenses incurred for a mammogram every 2 years, or annually if 
 ordered by a provider of health care, for women 40 years of age or older; and
(k) Deoxyribonucleic acid testing for high-risk strains of human papillomavirus every 3 years for women 30 years of age and older.